Artiva Biotherapeutics Inc
NASDAQ:ARTV

Watchlist Manager
Artiva Biotherapeutics Inc Logo
Artiva Biotherapeutics Inc
NASDAQ:ARTV
Watchlist
Price: 4.18 USD -5.64%
Market Cap: 53.7m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ARTV.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ARTV Intrinsic Value
Not Available
Base Case Scenario
Compare ARTV to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ARTV?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Artiva Biotherapeutics Inc

Balance Sheet Decomposition
Artiva Biotherapeutics Inc

Current Assets 129.5m
Cash & Short-Term Investments 123m
Receivables 79k
Other Current Assets 6.5m
Non-Current Assets 19.3m
PP&E 18.5m
Other Non-Current Assets 879k
Current Liabilities 11.1m
Accounts Payable 848k
Accrued Liabilities 10.1m
Other Current Liabilities 148k
Non-Current Liabilities 8.5m
Other Non-Current Liabilities 8.5m
Efficiency

Free Cash Flow Analysis
Artiva Biotherapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Artiva Biotherapeutics Inc

Revenue
0 USD
Operating Expenses
-86.1m USD
Operating Income
-86.1m USD
Other Expenses
7m USD
Net Income
-79.2m USD
Fundamental Scores

ARTV Profitability Score
Profitability Due Diligence

Artiva Biotherapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
Negative ROE
hidden
Profitability
Score

Artiva Biotherapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ARTV Solvency Score
Solvency Due Diligence

Artiva Biotherapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Artiva Biotherapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ARTV Price Targets Summary
Artiva Biotherapeutics Inc

Wall Street analysts forecast ARTV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARTV is 17.34 USD with a low forecast of 10.1 USD and a high forecast of 24.15 USD.

Lowest
Price Target
10.1 USD
142% Upside
Average
Price Target
17.34 USD
315% Upside
Highest
Price Target
24.15 USD
478% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Artiva Biotherapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ARTV is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ARTV Insider Trading
Buy and sell transactions by insiders